+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Balloon Valvuloplasty Devices Market Size, Share and Trends Analysis Report by Application (Aortic Valve Stenosis, Pulmonary Valve Stenosis), End-use (Hospitals, Ambulatory Surgical Centers), and Region 2024-2030

  • PDF Icon

    Report

  • 100 Pages
  • September 2024
  • Region: Global
  • Grand View Research
  • ID: 6009836
The global balloon valvuloplasty devices market size is expected to reach USD 3.02 billion by 2030, registering a CAGR of 4.1% from 2024 to 2030. The increasing prevalence of cardiovascular diseases, including valvular heart diseases, new product launches, regulatory approvals, and advanced healthcare infrastructure, drives the demand for balloon valvuloplasty devices in North America. Rheumatic heart disease (RHD) is a serious cardiovascular condition that arises from damage to the heart valves due to rheumatic fever.

According to a report published by the American Heart Association in April 2024, valvular heart disease (VHD) is among the most prevalent health conditions in the U.S., affecting about 2.5% of the adult population. Aortic and mitral valve diseases are the most diagnosed types of VHD, further emphasizing the critical need for effective treatment options like balloon valvuloplasty devices to address this growing health concern.

Increasing awareness and screening programs fuel the market's growth. For instance, in September 2024, the Global Heart Hub initiated campaigns highlighting the rising prevalence of heart valve disease, which is expected to double by 2040 and triple by 2060. These efforts stress the critical role of early detection through regular medical check-ups. The organization aims to inform the public about the symptoms and available treatments, such as balloon valvuloplasty.

Balloon Valvuloplasty Devices Market Report Highlights

  • Based on application, the aortic valve stenosis segment held the largest share, over 64%, in 2023. The global rise in the incidence of valvular heart diseases and technological advancements drive the segment's growth
  • Based on end use, the hospital segment held the largest revenue share at 57.4% in 2023. The rising incidence of valvular heart diseases globally necessitates advanced solutions within hospitals to manage patient care effectively
  • North America dominated the market with a share of 41.4% in 2023, owing to the rising cases of cardiovascular diseases, including valvular heart diseases. Product launches, regulatory approvals, and advanced healthcare infrastructure drive the demand for balloon valvuloplasty devices
  • Market players operating in the balloon valvuloplasty devices market include B. Braun Interventional Systems, Inc., BD Interventional, Edwards Lifesciences, Boston Scientific Corporation, Getinge, Toray International America, Inc., Stryker, BrosMed Medical, Medtronic, Terumo Corporation, Philips

The leading players in the Balloon Valvuloplasty Devices market include:

  • B. Braun Interventional Systems, Inc.
  • BD Interventional
  • Edwards Lifesciences
  • Boston Scientific Corporation
  • Getinge
  • Toray International America, Inc
  • Stryker
  • BrosMed Medical
  • Medtronic
  • Terumo Corporation
  • Philips

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. End-use
1.2.3. Regional scope
1.2.4. Estimates and forecast timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity price analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application Segment
2.2.2. End-use Segment
2.2.3. Regional Outlook
2.3. Competitive Insights
Chapter 3. Global Balloon Valvuloplasty Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of valvular heart diseases
3.2.1.2. Technological advancements in balloon valvuloplasty devices
3.2.1.3. Increasing awareness and screening programs
3.2.2. Market restraint analysis
3.2.2.1. High cost associated with the devices and procedures
3.2.2.2. Regulatory compliance
3.3. Balloon Valvuloplasty Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Balloon Valvuloplasty Devices Market: Application Estimates & Trend Analysis
4.1. Balloon Valvuloplasty Devices Market: Application Dashboard
4.2. Balloon Valvuloplasty Devices Market: Application Movement Analysis
4.3. Balloon Valvuloplasty Devices Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
4.4. Aortic Valve Stenosis
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Pulmonary Valve Stenosis
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Balloon Valvuloplasty Devices Market: End-use Estimates & Trend Analysis
5.1. Balloon Valvuloplasty Devices Market: End-use Dashboard
5.2. Balloon Valvuloplasty Devices Market: End-use Movement Analysis
5.3. Balloon Valvuloplasty Devices Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Ambulatory Surgical Centers (ASCs)
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Cardiac Catheterization Labs
5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Balloon Valvuloplasty Devices Market: Regional Estimates & Trend Analysis by Country, Application, & End-use
6.1. Global Balloon Valvuloplasty Devices Market: Regional Dashboard
6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
6.3. North America
6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.3.2. U.S.
6.3.2.1. Key country dynamics
6.3.2.2. Regulatory framework/ reimbursement structure
6.3.2.3. Competitive scenario
6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
6.3.3. Canada
6.3.3.1. Key country dynamics
6.3.3.2. Regulatory framework/ reimbursement structure
6.3.3.3. Competitive scenario
6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
6.3.4. Mexico
6.3.4.1. Key country dynamics
6.3.4.2. Regulatory framework/ reimbursement structure
6.3.4.3. Competitive scenario
6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
6.4. Europe
6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.2. UK
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
6.4.4. France
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework/ reimbursement structure
6.4.4.3. Competitive scenario
6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
6.4.5. Italy
6.4.5.1. Key country dynamics
6.4.5.2. Regulatory framework/ reimbursement structure
6.4.5.3. Competitive scenario
6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
6.4.6. Spain
6.4.6.1. Key country dynamics
6.4.6.2. Regulatory framework/ reimbursement structure
6.4.6.3. Competitive scenario
6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Regulatory framework/ reimbursement structure
6.4.7.3. Competitive scenario
6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
6.4.8. Norway
6.4.8.1. Key country dynamics
6.4.8.2. Regulatory framework/ reimbursement structure
6.4.8.3. Competitive scenario
6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
6.4.9. Denmark
6.4.9.1. Key country dynamics
6.4.9.2. Regulatory framework/ reimbursement structure
6.4.9.3. Competitive scenario
6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
6.5.3. Japan
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
6.5.4. India
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
6.5.5. Australia
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
6.5.6. Thailand
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
6.5.7. South Korea
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
6.6. Latin America
6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.2. Brazil
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
6.6.3. Argentina
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
6.7. MEA
6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
6.7.3. South Africa
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
6.7.4. UAE
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Manufacturers
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. B. Braun Interventional Systems, Inc.
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. BD Interventional
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Edwards Lifesciences
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Boston Scientific Corporation
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Getinge
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Toray International America, Inc.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Stryker
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. BrosMed Medical
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Medtronic
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Terumo Corporation
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product benchmarking
7.3.13.4. Strategic initiatives
7.3.14. Philips
7.3.14.1. Company overview
7.3.14.2. Financial performance
7.3.14.3. Product benchmarking
7.3.14.4. Strategic initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. Global balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 4. Global balloon valvuloplasty devices market, by end-use, 2018 - 2030
Table 5. Global balloon valvuloplasty devices market, by region, 2018 - 2030 (USD Million)
Table 5. North America balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
Table 6. North America balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 7. North America balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 8. U.S. balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 9. U.S. balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 10. Canada balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 11. Canada balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 12. Mexico balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 13. Mexico balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 14. Europe balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
Table 15. Europe balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 16. Europe balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 17. U.K. balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 18. U.K. balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 19. Germany balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 20. Germany balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 21. France balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 22. France balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 23. Italy balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 24. Italy balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 25. Spain balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 26. Spain balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 27. Denmark balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 28. Denmark balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 29. Sweden balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 30. Sweden balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 31. Norway balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 32. Norway balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 33. Asia Pacific balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
Table 34. Asia Pacific balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 35. Asia Pacific balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 36. Japan balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 37. Japan balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 38. China balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 39. China balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 40. India balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 41. India balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 42. Australia balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
Table 43. Australia balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 44. Australia balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 45. Thailand balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 46. Thailand balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 47. South Korea balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 48. South Korea balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 49. Latin America balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
Table 50. Latin America balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 51. Latin America balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 52. Brazil balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 53. Brazil balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 54. Argentina balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 55. Argentina balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 56. MEA balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
Table 57. MEA balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 58. MEA balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 59. South Africa balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 60. South Africa balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 61. Saudi Arabia balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 62. Saudi Arabia balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 63. UAE balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 64. UAE balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 65. Kuwait balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
Table 66. Kuwait balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
Table 67. Participant’s overview
Table 68. Financial performance
Table 69. Key companies undergoing expansions
Table 70. Key companies undergoing acquisitions
Table 71. Key companies undergoing collaborations
Table 72. Key companies launching new products
Table 73. Key companies undergoing partnerships
Table 74. Key companies undertaking other strategies
List of Figures
Fig. 1 Balloon valvuloplasty devices market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Balloon valvuloplasty devices market revenues, 2023, (USD Millions)
Fig. 9 Market driver relevance analysis (Current & future impact)
Fig. 10 Market restraint relevance analysis (Current & future impact)
Fig. 11 Porter’s five forces analysis
Fig. 12 PESTLE analysis
Fig. 13 Balloon valvuloplasty devices market application outlook:
Fig. 14 Balloon valvuloplasty devices market: application movement analysis
Fig. 15 Global aortic valve stenosis market, 2018 - 2030 (USD Million)
Fig. 16 Global pulmonary valve stenosis market, 2018 - 2030 (USD Million)
Fig. 17 Balloon valvuloplasty devices market end-use outlook:
Fig. 18 Balloon valvuloplasty devices market: end-use movement analysis
Fig. 19 Global hospitals market, 2018 - 2030 (USD Million)
Fig. 20 Global ambulatory surgical centers (ASCs) market, 2018 - 2030 (USD Million)
Fig. 21 Global cardiac catheterization labs market, 2018 - 2030 (USD Million)
Fig. 22 Regional market place: Key takeaways
Fig. 23 North America balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
Fig. 24 U.S. balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
Fig. 25 Canada balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
Fig. 26 Mexico balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
Fig. 27 Europe balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
Fig. 28 Germany balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
Fig. 29 U.K. balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
Fig. 30 France balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
Fig. 31 Italy balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
Fig. 32 Spain balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
Fig. 33 Asia Pacific balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
Fig. 34 Japan balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
Fig. 35 China balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
Fig. 36 India balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
Fig. 37 Australia balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
Fig. 38 Latin America balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
Fig. 39 Brazil balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
Fig. 40 MEA balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
Fig. 41 South Africa balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
Fig. 42 Saudi Arabia balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
Fig. 43 Market Participant Categorization
Fig. 44 Strategy mapping

Companies Mentioned

The leading players in the Balloon Valvuloplasty Devices market include:
  • B. Braun Interventional Systems, Inc.
  • BD Interventional
  • Edwards Lifesciences
  • Boston Scientific Corporation
  • Getinge
  • Toray International America, Inc
  • Stryker
  • BrosMed Medical
  • Medtronic
  • Terumo Corporation
  • Philips

Methodology

Loading
LOADING...

Table Information